IPSC vs ROL · rev $6.6M vs P/E 41, rev $3.39B
Century Therapeutics Inc (IPSC) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
IPSC currently screens at market cap $47.8M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the IPSC and ROL stock pages for the full models.
Not investment advice.